Search
for
Sort by
Research 31–60 of 213
- Alopecia in Association with Malignancy: A Review
- Distinctive histopathologic findings in linear morphea (<i>en coup de sabre</i>) alopecia
- Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens
- Therapeutic Effect of Superficial Scalp Hypothermia on Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Drug-induced scarring and permanent alopecia
- EFFICACY AND SAFETY OF STANDARDIZED CINNAMON BARK EXTRACT FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED WEIGHT LOSS AND ALOPECIA IN PATIENTS WITH BREAST CANCER: A RANDOMIZED, DOUBLE-BLIND, AND PLACEBO-CONTROLLED STUDY
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Topical minoxidil and dietary supplement for the treatment of chemotherapy-induced alopecia in childhood: a retrospective cohort study
- "A Natural Product that Accelerates Hair Growth in Women with Chemotherapy-Induced Alopecia"
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
- 5-Bromo-2′-deoxyuridine induced effluvium via p53-mediated CD326-positive keratinocyte apoptosis in C57BL/6 mice
- Physiological Doses of Red Light Induce IL‐4 Release in Cocultures between Human Keratinocytes and Immune Cells
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- Dermatological adverse events with taxane chemotherapy
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- The efficacy of scalp cooling in patients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial
- 5-Fluorouracil induces hair loss by inhibiting β-catenin signaling and angiogenesis
- Pellagroid dermatitis during a ketogenic diet and anti-epileptic therapy.
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- The financial burden of scalp cooling therapy: A nonprofit organization data analysis
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Low-Dose Oral Minoxidil During Chemotherapy: A Review of the Mechanism and Current Evidence
- Hair & Cutaneous Development
- Mucocutaneous reactions to chemotherapy
- DRUG‐ASSOCIATED ALOPECIA